Bibliographic information
GuidelineWHO guidelines on tuberculosis infection prevention and control: 2019 update
Year of Publication2019
Issuing InstitutionWHO
Recommendation
Maintained
Patients with multidrug-resistant tuberculosis (MDR-TB) should be treated using mainly ambulatory care rather than models of care based principally on hospitalization
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update
Year2011
InstitutionWorld Health Organization
Guideline
Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update
Year2011
InstitutionWorld Health Organization
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization